# Study of Gardasil in Mid-Adult Males (MAM)

> **NCT01432574** · PHASE2 · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 150 (actual)

## Conditions studied

- Human Papillomavirus

## Interventions

- **BIOLOGICAL:** Gardasil

## Key facts

- **NCT ID:** NCT01432574
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-19
- **Primary completion:** 2014-05-23
- **Final completion:** 2020-11-03
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2021-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01432574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01432574, "Study of Gardasil in Mid-Adult Males (MAM)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01432574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*